Science-Technology Linkages in an Emerging Research Platform: The Case of Combinatorial Chemistry and Biology

This article focuses on issues concerning science and technology relationships posed by the emergence of a new drug discovery method, namely, combinatorial chemistry and biology. We assess the scientific content of combinatorial chemistry and biology using citations in patents to scientific journals and compare this research platform with biotechnology. We also identify the institutional affiliation of all the authors of the cited papers, which leads us to an analysis of knowledge spillovers between the main participants in the research network. Finally, we examine the relevance of localisation in the process of knowledge exchange with regard to EU countries and the US. The result of the analysis provides evidence to support the view that the inventive capacity of a country is dependent upon the basic research which is carried out, especially in universities and public research centres located in the inventor's country.

[1]  E. Gordon,et al.  Strategy and Tactics in Combinatorial Organic Synthesis. Applications to Drug Discovery , 2010 .

[2]  Benoît Godin,et al.  Research and the practice of publication in industries , 1996 .

[3]  M. J. Gardner,et al.  Combinatorial Synthesis ‐ The Design of Compound Libraries and Their Application to Drug Discovery , 1995 .

[4]  R. Houghten.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Á. Furka,et al.  General method for rapid synthesis of multicomponent peptide mixtures. , 2009, International journal of peptide and protein research.

[6]  S. P. Fodor,et al.  Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.

[7]  Henk F. Moed,et al.  An exploration of the science base of recent technology , 1990 .

[8]  M. Gallop,et al.  Combinatorial chemistry. , 1998, Current Opinion in Chemical Biology.

[9]  J. Ellman,et al.  Combinatorial chemistry and new drugs. , 1997, Scientific American.

[10]  Stu Borman,et al.  COMBINATORIAL CHEMISTRY: Researchers continue to refine techniques for identifying potential drugs in 'libraries' of small organic molecules , 1997 .

[11]  Stefan H. Thomke,et al.  Modes of experimentation: an innovation process--and competitive--variable , 1998 .

[12]  P. Collins,et al.  Citations in patents to the basic research literature , 1988 .

[13]  N. Rosenberg.  Why do firms do basic research (with their own money) , 1990 .

[14]  Keith Pavitt,et al.  Key National Factors in the Emergence of Computational Chemistry Firms , 1997 .

[15]  Richard R. Nelson,et al.  On the Sources and Significance of Interindustry Differences in Technological Opportunities , 1995 .

[16]  W. Bains,et al.  The Cost of Delivering Drugs Without Needles , 1995, Bio/Technology.

[17]  Á. Furka.  History of combinatorial chemistry , 1995 .

[18]  S. P. Fodor,et al.  Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. , 1994, Journal of medicinal chemistry.

[19]  A. Jaffe.  Real Effects of Academic Research , 1989 .

[20]  Francis Narin,et al.  Status report: Linkage between technology and science , 1992 .

[21]  David J. Ecker,et al.  Combinatorial Drug Discovery: Which Methods Will Produce the Greatest Value? , 1995, Bio/Technology.

[22]  Bart Verspagen.  Large Firms and Knowledge Flows in the Dutch R&D System : A Case Study of Philips Electronics , 1998 .

[23]  M Lebl,et al.  Parallel personal comments on "classical" papers in combinatorial chemistry. , 1999, Journal of combinatorial chemistry.

[24]  Francis Narin,et al.  Linkage between patents and papers: An interim EPO/US comparison , 2006, Scientometrics.

[25]  Vicki Glaser.  Drug companies like combinatorial chemistry , 1995, Bio/Technology.

[26]  Mark P. Carpenter,et al.  Linkage Between Basic Research Literature and Patents , 1980 .

[27]  Ulrich Schmoch,et al.  Indicators and the relations between science and technology , 2006, Scientometrics.

[28]  Hariolf Grupp,et al.  Perceptions of Scientification of Innovation as Measured by Referencing Between Patents and Papers: Dynamics in Science-Based Fields of Technology , 1992 .

[29]  H. M. Geysen,et al.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Luigi Orsenigo,et al.  The Emergence of Biotechnology: Institutions and Markets in Industrial Innovation , 1989 .

[31]  Barry A. Bunin,et al.  A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives , 1992 .

[32]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[33]  Francis Narin,et al.  Human genetic technology: exploring the links between science and innovation , 1996 .

[34]  Luigi Orsenigo,et al.  The emergence of biotechnology , 1989 .

[35]  Kimberly S. Hamilton,et al.  The increasing linkage between U.S. technology and public science , 1997 .